Blue states sue Trump administration in bid to undo freeze on billions in public education funds
The new suit represents the latest clash between states and the federal government over the Trump administration's decision to pause or claw back federal aid.
In other cases dating back to the opening weeks of President Donald Trump's second term, federal courts have at times sided against the administration's efforts to freeze federal funds, though the administration scored a key win at the Supreme Court in April.
In the case at hand, more than 20 Democratic state attorneys general and two Democratic governors are challenging the administration's decision late last month to pause disbursement of education funds for six programs pending a review of how consistent the programs are with Trump's own priorities.
Among the targeted initiatives are ones that help immigrant students attain English proficiency, fund after-school and summer programs, and support the hiring and retention of teachers in low-income areas.
The administration's withholding of the funds, the states say in the suit, runs afoul of Congress' decision over the years to provide the federal aid and the government's requirement to spend the money. Historically, the money has been made available to states starting around July 1.
'Defendants' actions now jeopardize these critical programs – the loss of which has irreparably harmed and will irreparably harm the Plaintiff States, their schools, and the students and families they serve,' the suit states.
The states and attorneys general are asking a federal court in Rhode Island to rule that the funding freeze is unconstitutional and order the administration to stop implementing its plans.
CNN has reached out to the Department of Education for comment on the lawsuit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Trump doubles down on Most Favored Nation plan to target drug prices
US President Donald Trump has called on pharmaceutical manufacturers to lower US drug prices in line with the Most Favored Nation (MFN) policy first proposed in an executive order in May. On 31 July, the White House said letters were sent to leading pharmaceutical manufacturers like AstraZeneca, AbbVie, Eli Lilly, Regeneron, Novartis, Pfizer, and more, calling on them to take steps to lower drug prices in the US such that they match the lowest prices in other developed countries within the next 60 days. President Trump also shared many of these letters on the social media platform Truth Social. While this is not the first time the administration has floated the MFN policy, this time, the language used to address pharma companies is more aggressive. If the companies do not comply, the order states, the federal government 'will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices.' In response to this statement, a spokesperson for the industry body BIO said, 'We share the Administration's goal of ending foreign freeloading on American innovation. But importing socialist price controls would lead only to fewer new medicines and the rationing of healthcare for Americans and would strengthen and embolden foreign adversaries whose goal is to dominate the world in biotechnology.' The BIO spokesperson said eliminating the middlemen, ending the abuse of drug reimbursement programs like 340B would be a way to simplify the system, protect patients and narrow the pricing gap between the US and other developed countries. 'Middlemen' or pharmacy benefit managers (PBMs) are often blamed by the pharmaceutical companies for high drug prices. PBMs on their part have said they negotiate with different stakeholders to drive down costs, and pass on savings obtained through rebates and discounts to health plans. The letter to the manufacturers implores them to provide drug at 'MFN rates' to all Medicaid patients, and commit to providing these prices for newly launched drugs to all major US buyers like Medicare and commercial plans. The latest announcement also calls on drug manufacturers to opt in for platforms where drugs can be sold directly to patients at prices that are comparable to those in developed nations, which are currently offered to third party payers. Among the letters posted on Truth Social, Trump directly called on several CEOs like Albert Bourla of Pfizer, and Leonard Schleifer of Regeneron, by using their first names instead of a formal address. Several countries use international reference pricing as a strategy in their health systems. However, chief among the criticism following the May executive order has been the lack of details. Industry experts have highlighted a lack of clarity on how any potential list price changes will affect the prices patients pay at the pharmacy counter given the complex dynamics and multiple stakeholders in the US healthcare system. There is also a concern that if the US implements reference pricing, it could influence when companies choose to launch drugs in certain ex-US markets to avoid those potentially lower prices from being used as references. Furthermore, pharma companies have chosen the litigation route to fight legislative changes targeting drug prices, like the Inflation Reduction Act, and the same could be seen with the MFN executive order, as per a Bank of America report. "Trump doubles down on Most Favored Nation plan to target drug prices" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. 登入存取你的投資組合
Yahoo
17 minutes ago
- Yahoo
Trump finally announces new tariff plan hours before deadline - but delays them yet again
The Trump administration announced its new trade policy and its tariff plan on Thursday, just hours before the August 1 trade deadline. On Thursday night, the Trump White House announced that a "universal" tariff for goods coming into U.S. will remain at 10 percent. That is the same level that President Donald Trump set during his "Liberation Day" even in early April when he first announced the tariffs. However, that 10 percent rate will only apply to countries with a trade surplus — in other words, countries to which the U.S,. exports more than it imports. A senior administration official told the Associated Press that most countries have trade surpluses with the U.S. The new tariff policy will not go into effect on Friday. Trump has delayed the tariffs for another week, until August 7, reportedly to give U.S. Customs and Border Protection time to make changes in how it policies incoming goods and to collect the new duties from imports.
Yahoo
17 minutes ago
- Yahoo
DOGE Has Wasted Billions Paying People Not To Work, Report Finds
The so-called Department of Government Efficiency, a project that President Donald Trump's administration touted as the flagship endeavor in its 'war on waste,' has generated $21.7 billion in waste since its launch, Democrats claimed in a new report Thursday. The staggering figure comes from Democrats on the Senate Permanent Subcommittee on Investigations, spearheaded by Sen. Richard Blumenthal (Conn.), who released their findings in a 55-page report on losses accrued by DOGE, the brainchild of Trump and his billionaire friend-turned-enemy Elon Musk. The results, the Democrats say, are the unsurprising outcome of a tech CEO with zero government experience taking charge of a massive federal spending overhaul, promising it was 'going to be a revolution.' 'By prioritizing disruption over governance and failing to identify solutions for any of the problems it purported to solve, DOGE has created its own forms of waste,' the report stated. The waste found in the investigation was largely generated by the Trump administration paying hundreds of thousands of employees to stop working. That includes $14.8 billion under the deferred resignation program, which has paid around 200,000 employees not to work throughout the last eight months. Sources told The Washington Post on Thursday that there are currently more than 154,000 federal employees in that program being paid through Sept. 30 or to the end of the year. The $21.7 billion total also includes $6.1 billion for paying more than 100,000 employees who were involuntarily separated from federal service or put on prolonged periods of administrative leave. One of the federal employees put on leave six months ago by DOGE says they have no idea when their full pay and other benefits will end — or if they'll be asked to return to the job they loved. 'Maybe this week, maybe next week, maybe the week after, or maybe next month,' the worker, granted anonymity by HuffPost, said. 'We all just kind of guess and make predictions, and we're usually wrong.' They're hopeful to get some news in the next few weeks, but they aren't holding their breath. 'I've said that many, many times over the last six months, and here I am still,' they said. Starting a different job would force them to formally quit their government job, foregoing severance and losing their place at the front of the line for future government work. Seeing the $21.7 billion figure is especially frustrating, knowing that important research has ceased and grants have stopped going out. 'DOGE really forced waste, fraud and abuse by eliminating so much of the federal workforce,' the worker said. The waste found in the report also includes $110 million on food aid and medical supplies that are spoiling in warehouses, awaiting destruction. That will be destroyed 'at a further cost to taxpayers,' the report found. In one example provided, the U.S. is spending approximately $160,000 to incinerate $9.7 million in contraceptives because it allegedly refused to sell them to a third party at anything below full market value. Another $66 million in the total comes from slapping high-level employees with entry-level tasks, including more than $138,000 'for paying scientists to check guests in at national parks,' per the findings. DOGE mandates for people to move closer to physical government offices cost another $41 million in relocation fees. The $21.7 billion does not include the government's legal expenses from DOGE-related lawsuits, the report noted, nor does it include some indirect costs, like the economic consequences of weakened disaster response agencies or stifled innovation from canceled grants. 'The full extent of the waste and harm caused by DOGE's disruptive activities is difficult to quantify because costs remain hidden and many of the consequences have yet to fully materialize,' the report stated. The White House did not immediately respond when reached for comment about the report. DOGE claims it has saved Americans $199 billion so far, amounting to $1,236.02 per taxpayer. The report called on the Offices of Inspectors General to launch an investigation into DOGE, which has continued despite Musk's fallout with Trump and departure from the department. Per the DOGE website, it terminated numerous employees from the departments of the Interior, Health and Human Services and Homeland Security, among others, just last week. 'Fully understanding and quantifying the true costs of DOGE's operations,' the report concluded, 'is crucial to holding the administration accountable and preventing similar detrimental 'efficiency' schemes in the future.' Related... DOGE Cut National Weather Service Jobs. Trump's NOAA Pick Now Says He Wants To Fill Them. Musk's DOGE Takeover Of Peace Institute Left Building With Rats And Roaches Supreme Court Allows DOGE Team To Access Social Security Systems With Data On Millions
